Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV zanamivir in neonates and infants with complicated influenza
2024-510663-34-00Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of zanamivir in influenza, sponsored by GSK. Primary endpoints: Area under the serum concentration-time curve (AUC), Maximum serum concentration (Cmax) and 2 more. Started Jan 2021; status: completed.
02
Drugs
zanamivir
03
Conditions
influenza
Beyond the preview
Go deeper on 2024-510663-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510663-34-00.